Patent 10426509 was granted and assigned to Neotract on October, 2019 by the United States Patent and Trademark Office.
A system and associated method for altering or destroying tissues and anatomical or other structures in medical applications for the purpose of treating diseases or disorders. In one aspect, the system includes a device configured to deploy devices for altering the lobes of a prostate.